This was interesting re the much discussed Ionis relationship:
Percheron remains obligated to use commercially reasonable efforts to bring products into commercial use as quickly as is reasonably possible. Percheron also retains access to relevant Ionis know-how and an obligation to pay certain royalties to Ionis based on commercialization proceeds received by Percheron. The revised agreement, now titled the 'Royalty Agreement', otherwise serves to retire certain research and development-focused provisions of the original which are no longer applicable.
- Forums
- ASX - By Stock
- PER
- Ann: Quarterly Activities Report and Appendix 4C
Ann: Quarterly Activities Report and Appendix 4C, page-2
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.001(1.16%) |
Mkt cap ! $88.12M |
Open | High | Low | Value | Volume |
8.6¢ | 8.8¢ | 8.5¢ | $290.3K | 3.355M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 322623 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.8¢ | 227962 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 322623 | 0.085 |
1 | 200000 | 0.083 |
2 | 29125 | 0.082 |
4 | 326000 | 0.081 |
9 | 925186 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 227962 | 2 |
0.089 | 200000 | 1 |
0.090 | 604764 | 4 |
0.092 | 200000 | 1 |
0.093 | 200000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online